Gainers
TravelCenters of America Inc. (NASDAQ: TA) shares jumped 70.5% to $84.32 after BP announced it will acquire the company for $86 per share in cash.
EMA Marketing Authorisation Application for leniolisib changed to standard review timetable
LEIDEN, Netherlands, Feb. 16, 2023 /PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the
Pharming Group N.V. (NASDAQ:PHAR) announced data from an interim analysis of its open-label extension study of leniolisib for activated phosphoinositide…
V. Koneti Rao, MD, shared new evidence of long-term safety and hematologic response in patients who received leniolisib to treat APDS, a rare primary immunodeficiency
Interim analysis demonstrated leniolisib to be
Leniolisib was well tolerated and significant improvement over placebo was notable in the co-primary endpoints, reflecting a favorable impact on patients' immune dysregulation and deficiency
The peer-reviewed